CLEC7A and fungal infectious disease: To validate signaling via Dectin-1, we treated both iDC and Dex-DC with a specific anti-Dectin-1 antibody (5 μg/ml) and found ROS-levels equivalent to control conditions, indicating a Dectin-1-mediated ROS release after fungal infections.